StonvexLoading…
StonvexStonvexStonvexCore line items from FRPT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.10B | $975.18M | $766.89M | $595.34M |
Operating Income | $75.67M | $38.00M | $-30.45M | $-51.98M |
Net Income | $139.14M | $46.92M | $-33.61M | $-59.49M |
EPS (Diluted) | $2.64 | $0.93 | $-0.70 | $-1.29 |
Total Assets | $1.78B | $1.57B | $1.46B | $1.13B |
Total Liabilities | $569.12M | $519.52M | $510.97M | $93.81M |
Cash & Equivalents | $277.98M | $268.63M | $296.87M | $132.74M |
Free Cash Flow OCF − CapEx | $12.38M | $-32.80M | $-163.15M | $-273.30M |
Shares Outstanding | 48.97M | 48.70M | 48.26M | 48.04M |